Randomized controlled trial (therapeutic vs. placebo CPAP) including 46 patients with obstructive sleep apnea (OSA) to define the physiological effects of continuous positive airway pressure (CPAP) therapy withdrawal on myocardial perfusion and dermal and renal microvascular function during a 2 week period.
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
TRIPLE
Enrollment
45
CPAP (continuous positive airway pressure) with subtherapeutic pressure during two weeks
Continue treatment with therapeutic continuous positive airway pressure device
University Hospital Zurich, Division of Pneumology
Zurich, Canton of Zurich, Switzerland
hyperaemic myocardial blood flow
Time frame: 2 weeks
Coronary flow reserve
Coronary flow reserve determined by PET
Time frame: 2 weeks
Urine albumine excretion rate
Time frame: 2 weeks
Dermal microvascular vasodilatory response
Time frame: 2 weeks
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.